As discussed, troponin elevation (illustrating myocardial injury) is common among hospitalized patients with COVID-19 (incidence ranging from 14–44% across 18 studies), with higher levels correlated with worse outcomes.2 Increases in markers of inflammation and thrombogenicity such as C-reactive protein, erythrocyte sedimentation rate, ferritin, interleukin-6, lactate dehydrogenase, fibrinogen, and D-dimer are associated with higher mortality.18,22. The gene discussed is CRP; the disease is COVID-19.